| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/05/2009 | US20090035266 Immunogenic peptides and methods of use |
| 02/05/2009 | US20090035261 for treating degenerative cartilaginous disorders and other inflammatory diseases; inhibiting the proliferation of T-lymphocytes; modulating infiltration of inflammatory cells into a tissue of a mammal |
| 02/05/2009 | US20090035259 Group a streptococcal vaccines |
| 02/05/2009 | US20090035254 IL-21 Variants |
| 02/05/2009 | US20090035252 Method of inducing a CTL response |
| 02/05/2009 | US20090035249 Method of inhibiting proliferation of Escherichia coli |
| 02/05/2009 | CA2695660A1 Adefovir dipivoxil crystalline monohydrate form |
| 02/05/2009 | CA2694363A1 Monomeric vhh domain derived from anti-vp6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections |
| 02/04/2009 | EP2020445A1 Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease |
| 02/04/2009 | EP2020416A1 Phosphonocephem compound |
| 02/04/2009 | EP2020409A1 New piperidinyl derivatives as modulators of chemokine receptor activity |
| 02/04/2009 | EP2020406A1 New antimicrobial compounds, their synthesis and their use for treatment of mammalian infection |
| 02/04/2009 | EP2020242A2 Improved Topical Medicaments and Methods for Photodynamic Treatment of Disease |
| 02/04/2009 | EP2020239A1 Use of IL-174 agonists for treating infectious diseases |
| 02/04/2009 | EP2019830A2 Inhibitors of secretion of hepatitis b virus antigens for treatment of a chronic hepatitis virus |
| 02/04/2009 | EP2019825A1 Inhibitors of human immunodeficiency virus replication |
| 02/04/2009 | EP2019819A1 Novel peptide derivatives useful as antimicrobial agents for treating wounds |
| 02/04/2009 | EP2019689A2 Pharmaceutical composition and vaccine against staphylococcal infections |
| 02/04/2009 | EP2019687A2 Vaccine against streptococci |
| 02/04/2009 | CN101360823A Recombinant multivalent vaccine |
| 02/04/2009 | CN101360821A Stabilizing formulations for recombinant viruses |
| 02/04/2009 | CN101360752A Hiv整合酶抑制剂 Hiv integrase inhibitors |
| 02/04/2009 | CN101360533A Pathogen - controlling products |
| 02/04/2009 | CN101358182A Recombinant baculovirus strain of porcine circovirus type 2 Cap protein expression, construction method and application thereof |
| 02/04/2009 | CN101357942A Monoclonal antibody, Fab antibody and application for neutralizing enterohemorrhagic escherichia coli o157:H7 shiga toxin II |
| 02/04/2009 | CN101357934A Method for preparing high purity betulinic acid |
| 02/04/2009 | CN101357930A Adefovir dipivoxil preparation method |
| 02/04/2009 | CN101357929A Cephalosporin derivative containing sulfhydryl thiadiazole |
| 02/04/2009 | CN101357920A Penem derivative containing sulfhydryl pyrrolidine formamido triazine |
| 02/04/2009 | CN101357919A Penem derivative containing sulfhydryl formamide benzenesulfonyl pyrrolidine |
| 02/04/2009 | CN101357918A Penem derivative containing isothioureido sulfhydryl pyrrolidine |
| 02/04/2009 | CN101357917A Carbapenem compound containing formyl hydrazino |
| 02/04/2009 | CN101357916A Penem compound containing dihydroimidazole formamido |
| 02/04/2009 | CN101357906A Novel triazolols antifungal compound, preparation method and application thereof |
| 02/04/2009 | CN101357888A Method for preparing ferrous rosmarinci acid and magnesian rosmarinci acid and antibacterial activity application thereof |
| 02/04/2009 | CN101357228A Preparation method of hepatitis b human immunoglobulin for intravenous injection |
| 02/04/2009 | CN101357226A Replication-deficient human type 3 adenovirus vaccine |
| 02/04/2009 | CN101357219A Medicine for treating chronic hepatitis b |
| 02/04/2009 | CN101357216A Production method of Jinggandu oral liquid |
| 02/04/2009 | CN101357215A Medicine combination for treating viral hepatitis and quality control method thereof |
| 02/04/2009 | CN101357201A Multipurpose traditional Chinese medicine and preparation method thereof |
| 02/04/2009 | CN101357194A Traditional Chinese medicine for treating Pafeng disease |
| 02/04/2009 | CN101357184A Chinese traditional medicine for treating hepatosis and preparation method thereof |
| 02/04/2009 | CN101357165A External medicine for treating parotiditis and preparation method thereof |
| 02/04/2009 | CN101357164A Compound yellow-flower foot-hand bathing agent |
| 02/04/2009 | CN101357163A External medicine for treating wind-cold type common cold and preparation method thereof |
| 02/04/2009 | CN101357159A Shiji powder for preventing and treating taura syndrome virus and preparation method thereof |
| 02/04/2009 | CN101357154A Chinese herbal medicine composition with bacteriostasis, anti-inflammation hemostasia effect |
| 02/04/2009 | CN101357146A Preparation method of chimonanthus nitens valid target, production method and use of formulation thereof |
| 02/04/2009 | CN101357129A Medicine composition containing silymarin and kurainone or matrine and use thereof |
| 02/04/2009 | CN101357123A New antivirus, antibacterial method for animal and plant and product thereof |
| 02/04/2009 | CN100457914C Recombinant protein production in human cell using sequences encoding adenovirus E1 protein |
| 02/04/2009 | CN100457912C Recombinant Ag85B bacillus Calmette-Guerin vaccine |
| 02/04/2009 | CN100457907C Recombinant helicobacter pylori outer-membrane protein 15 |
| 02/04/2009 | CN100457776C Hepatitis c virus NS5B polymerase inhibitor binding pocket |
| 02/04/2009 | CN100457754C Substituted indolepyridinium as anti-infective compounds |
| 02/04/2009 | CN100457748C Novel phenolic acid compounds of tanshin polyphenolic acid N and application thereof |
| 02/04/2009 | CN100457179C Method and composition for oral vaccination |
| 02/04/2009 | CN100457163C Medicine for treating virus diarrhea and its preparation method |
| 02/04/2009 | CN100457133C Application of Qiannianai in preparing medicine for treating chronic viral hepatitis B |
| 02/04/2009 | CN100457127C Medicinal herb solvent extract for treating hepatic disease |
| 02/04/2009 | CN100457118C 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections |
| 02/04/2009 | CN100457113C Preparation method of bacteriostatic agent sulfadiazine cerium |
| 02/04/2009 | CN100457112C Combination of medication of containing kurarinone and glycyrrhetic acid, and application |
| 02/04/2009 | CN100457096C An elemene formulation and preparation method thereof |
| 02/04/2009 | CN100457093C Chinese medicinal preparation for treating liver cancer, hepatitis B cirrhosis and preventing liver fibrillation and preparation thereof |
| 02/04/2009 | CN100457091C Preparation method of dripping pills of clove leaf |
| 02/04/2009 | CN100457089C Solid liposome nanoparticles of arenobufagin and preparation method thereof |
| 02/04/2009 | CN100457088C Pharmaceutical composition comprising lipids comprising polar and nonpolar moiety parts |
| 02/04/2009 | CN100457086C Aseptic medicine composition |
| 02/04/2009 | CN100457084C Nanometer silver type external use antibiotic gel for female external use and its preparation method |
| 02/03/2009 | US7485713 Polypeptides comprising growth hormone receptor extracellular domain and glycosylphosphatidylinositol |
| 02/03/2009 | US7485656 Fluconazole, a compound selected from a group consisting of fatty acid, fatty alcohol, higher fatty acid ester and lower alcohol and a base; favorable absorption and delivery through the human skin; low skin stimulation; stability; spreading |
| 02/03/2009 | US7485642 Administering levosimendan or a salt thereof |
| 02/03/2009 | US7485639 Well tolerated; intracellularly increasing cAMP; antiasthmatics, antiinflammatories: regulation of eosinophiles activation and degranulation |
| 02/03/2009 | US7485634 Methods for modulating the activity of receptors are provided. In particular compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of |
| 02/03/2009 | US7485633 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
| 02/03/2009 | US7485632 Cephalosporins |
| 02/03/2009 | US7485628 Inhibition of STAT-1 |
| 02/03/2009 | US7485327 For use in pharmaceuticals, dietetics and/or cosmetics; anticancer agents; for treatment of vision defects and periodontal disease |
| 02/03/2009 | US7485319 Doxycycline metal complex in a solid dosage form |
| 02/03/2009 | US7485313 Administering an isolated and purified recombinant Chlamydia trachomatis pgp3 protein having its native amino acid conformation to elicit an immune response to a recombinant Chlamydia trachomatis pgp3 protein |
| 02/03/2009 | US7485285 Delivery of antidepressants through an inhalation route |
| 02/03/2009 | CA2361377C Novel mucosal delivery system |
| 02/03/2009 | CA2322868C Acylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| 02/03/2009 | CA2275321C Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation |
| 02/03/2009 | CA2223567C Modified meningococcal polysaccharide conjugate vaccines |
| 02/03/2009 | CA2152066C Protein conferring an inducible resistance to glycopeptides, particularly in gram-positive bacteria |
| 02/03/2009 | CA1341590C Human immune interferon |
| 01/30/2009 | CA2595671A1 Method and system for producing medicinal alcohol as a prophylatic or remedy for cancer, hiv, aids and autoimmune diseases |
| 01/29/2009 | WO2009015000A1 Pyrazole urea derivatives used as kinase inhibitors |
| 01/29/2009 | WO2009014730A1 Macrocyclic serine protease inhibitors |
| 01/29/2009 | WO2009014524A2 Anti-microbial photodynamic therapy |
| 01/29/2009 | WO2009014216A1 Antibody having inhibitory activity on infection with hepatitis c virus (hcv), and use thereof |
| 01/29/2009 | WO2009013543A2 Targeted binging agents directed to kdr and uses thereof - 035 |
| 01/29/2009 | WO2009013480A2 Antibacterial combination therapy |
| 01/29/2009 | WO2009013356A2 Anti-hiv tablet formulations comprising darunavir |
| 01/29/2009 | WO2009013166A1 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-1-propanone and use thereof as an antimicrobial active ingredient |
| 01/29/2009 | WO2009012944A1 A conjugate of an antibody against cd4 and antifusogenic peptides |
| 01/29/2009 | WO2009012910A1 Biologically-active stilbene derivatives and compositions thereof |